Sale!

EWSR1 Gene Ewing’s Sarcoma Test Cost

Original price was: 2,000 د.إ.Current price is: 1,500 د.إ.

-25%

The EWSR1 Gene Ewing’s Sarcoma Test is a sophisticated diagnostic procedure aimed at identifying the presence of specific genetic rearrangements associated with Ewing’s sarcoma, a rare type of cancer that typically affects bones or the soft tissue around bones. This test focuses on detecting abnormalities in the EWSR1 gene, which are crucial for diagnosing the condition, determining prognosis, and guiding treatment decisions.

Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing services, this test offers a reliable solution for patients and healthcare providers dealing with Ewing’s sarcoma. The test cost is set at 1500 AED, reflecting the comprehensive analysis and expert interpretation involved in identifying the genetic markers associated with this aggressive cancer. By opting for this test, patients can gain valuable insights into their condition, enabling timely and targeted treatment interventions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EWSR1 gene Ewing’s sarcoma Test – DNA Labs UAE

Test Name: EWSR1 gene Ewing’s sarcoma Test

Components: Paraffin embedded tissue blocks

Price: 1500.0 AED

Sample Condition: Tumor tissue

Report Delivery: 7-8 days

Method: FISH

Test type: Genetics

Doctor: Oncology

Test Department:

Pre Test Information: EWSR1 gene (Ewing’s sarcoma) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

The EWSR1 gene, also known as Ewing’s sarcoma breakpoint region 1, is a gene that plays a role in the development of Ewing’s sarcoma, a rare type of bone and soft tissue cancer. Ewing’s sarcoma is characterized by a chromosomal translocation that involves the fusion of the EWSR1 gene with a partner gene, most commonly the FLI1 gene.

This fusion gene produces an abnormal protein that is thought to contribute to the development of cancer. The EWSR1 gene is located on chromosome 22 and encodes a protein called RNA-binding protein EWS. This protein is involved in various cellular processes, including gene expression regulation, RNA splicing, and DNA repair.

The fusion of EWSR1 with a partner gene in Ewing’s sarcoma disrupts the normal function of the EWSR1 protein and leads to the formation of cancerous cells. Understanding the role of the EWSR1 gene in Ewing’s sarcoma has helped in the development of targeted therapies for this type of cancer.

Targeting the abnormal protein produced by the fusion gene has shown promise in treating Ewing’s sarcoma and improving patient outcomes.

Test Name EWSR1 gene Ewing’s sarcoma Test
Components Paraffin embedded tissue blocks
Price 1500.0 AED
Sample Condition Tumor tissue
Report Delivery 7-8 days
Method FISH
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information EWSR1 gene (Ewing’s sarcoma) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The EWSR1 gene, also known as Ewing’s sarcoma breakpoint region 1, is a gene that plays a role in the development of Ewing’s sarcoma, a rare type of bone and soft tissue cancer. Ewing’s sarcoma is characterized by a chromosomal translocation that involves the fusion of the EWSR1 gene with a partner gene, most commonly the FLI1 gene. This fusion gene produces an abnormal protein that is thought to contribute to the development of cancer.

The EWSR1 gene is located on chromosome 22 and encodes a protein called RNA-binding protein EWS. This protein is involved in various cellular processes, including gene expression regulation, RNA splicing, and DNA repair. The fusion of EWSR1 with a partner gene in Ewing’s sarcoma disrupts the normal function of the EWSR1 protein and leads to the formation of cancerous cells.

Understanding the role of the EWSR1 gene in Ewing’s sarcoma has helped in the development of targeted therapies for this type of cancer. Targeting the abnormal protein produced by the fusion gene has shown promise in treating Ewing’s sarcoma and improving patient outcomes.